Morpholine → HCID 21099114, compound
Reaction equation
[C:1]([Si:5]([CH3:30])([CH3:29])[O:6][CH2:7][CH2:8][C:9]1([CH2:26][CH2:27][CH3:28])[C:14]2[NH:15][C:16]3[C:17]([F:25])=[CH:18][CH:19]=[C:20]([C:22]([OH:24])=O)[C:21]=3[C:13]=2[CH2:12][CH2:11][O:10]1)([CH3:4])([CH3:3])[CH3:2].CCN=C=NCCCN(C)C.C1C=CC2N(O)N=NC=2C=1.C(N(C(C)C)CC)(C)C.[NH:61]1[CH2:66][CH2:65][O:64][CH2:63][CH2:62]1>CN(C=O)C.O>[C:1]([Si:5]([CH3:29])([CH3:30])[O:6][CH2:7][CH2:8][C:9]1([CH2:26][CH2:27][CH3:28])[C:14]2[NH:15][C:16]3[C:21]([C:13]=2[CH2:12][CH2:11][O:10]1)=[C:20]([C:22]([N:61]1[CH2:66][CH2:65][O:64][CH2:63][CH2:62]1)=[O:24])[CH:19]=[CH:18][C:17]=3[F:25])([CH3:3])([CH3:2])[CH3:4]Participants
Reactant 5
Product 1
Reagents, catalysts & solvents 2
Procedure
To a solution of 1-[2-(tert-butyl-dimethyl-silanyloxy)-ethyl]-8-fluoro-1-propyl-1,3,4,9-tetrahydro-pyrano[3,4-b]indole-5-carboxylic acid (6) (400 mg, 0.918 mmol), EDCI (211 mg, 1.10 mmol) and HOBt (186 mg, 1.38 mmol) in DMF ( 5 mL) was added diisopropylethylamine (0.80 mL, 4.59 mmol) at room temperature. Morpholine (0.12 mL, 1.38 mmol) was added to the mixture and the mixture was stirred overnight at room temperature. The solution was diluted with H2O (10 mL) and extracted with EtOAc (3×15 mL). The organic solution was brine washed (30 mL), dried (Na2SO4) and concentrated. The residue was purified by flash chromatography (silica, 50% EtOAc in hexanes) to give 415 mg (90%) of title compound as a colorless oil. 1H NMR (CDCl3): 300 MHz δ 9.38 (s, 1H), 6.77 (m, 2H), 3.86–3.20 (m, 12 H), 2.67 (m, 2H), 1.97–1.15 (m, 6H), 0.81 (s, 9H), 0.76 (t, J=7.34 Hz, 3H), 0.06 (s, 3H), 0.03 (s, 3H).
Workup
- extractionextracted with EtOAc (3×15 mL)
- washwashed (30 mL)
- dry with materialdried (Na2SO4)
- concentrationconcentrated
- customThe residue was purified by flash chromatography (silica, 50% EtOAc in hexanes)
Sources & evidence
- ORD record
- ord-61f3b02941bb44d29b7f5e55c23d3dbe
- Source dataset
- uspto-grants-2007_05
- Patent number
- US07217730B2
Reaction notes
Loading…